Spectrophotometric Method for Assay of Serum Antiprotease: Clinical Applications.
- 1 April 1949
- journal article
- research article
- Published by Frontiers Media SA in Experimental Biology and Medicine
- Vol. 70 (4) , 667-670
- https://doi.org/10.3181/00379727-70-17027
Abstract
A spectrophotometric method (Coleman Spectrophotometer, Model 14, set at 675 m[mu]) of assay of antiproteolytic material in the serum, using inhibition of trypsin digestion of fibrinogen, is descr. Tests were performed on 250 samples of blood from patients with various diseases and from control patients without evident disease. Using a normal control at 100%, an antiproteolytic titer below 103% could be considered negative (5% possible error), and a titer above 130% as indicative of malignant neoplasia (5% possible error). Titers between 103% and 130% must be considered as of doubtful significance. These results are comparable to those obtained by a previously descr. clot formation method.Keywords
This publication has 2 references indexed in Scilit:
- THE ANTIPROTEOLYTIC ACTIVITY OF SERUMThe Journal of general physiology, 1943
- THE ANTIPROTEOLYTIC ACTIVITY OF SERUMThe Journal of general physiology, 1943